fashion -WSS

fashion

author：comprehensive 2025-10-01 11:01:43 - browse：13449

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Feng Zhang, Grail founder join forces on new gene editing startup

WSS

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Eye stem cell transplant could help restore vision in injured people

Baltimore teen accused of firing into crowd during block party mass shooting

JPM: CVS says Medicare Advantage patients are impacting profits

Feng Zhang, Grail founder join forces on new gene editing startup

How a scoliosis diagnosis changed the life of one young dancer

focus

fashion

focus

Anesthesiologist group: stop taking Ozempic before surgery

Cancer drug shortages' outsize impact on ovarian cancer patients

Walensky prepares to leave CDC — and Congress — behind

New weight loss drugs work. But how can they best be used?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

FDA approves first treatment for ultra

Sports medicine is finally prioritizing gender equality

J&J to buy cancer drug developer Ambrx Biopharma

After affirmative action ruling, medical educators look to 'holistic review'

Antibiotic resistance and the global rise in human conflict

focus

Trump's false claims about Georgia's 2020 election long debunked

Burning questions for the 2024 JPM Healthcare Conference

Trump's false claims about Georgia's 2020 election long debunked

Listen: Racing for gene therapy & a pioneering approval

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Federal weight loss drug coverage is 30 years out of date

entertainment

focus

knowledge

focus